Scientists have designed a potential new class of drugs that may reduce the risk of cardiovascular disease by targeting a specific microbial pathway in the gut.
Unlike antibiotics, the new class of drugs prevents microbes from making a harmful molecule linked to heart disease without killing the microbes, which are part of the gut flora and may be beneficial to overall health.
The study, published in the journal Nature Medicine, found that the new drugs reversed two major risk factors for cardiovascular disease - increased platelet responsiveness and excessive clot formation - in mice,
Disclaimer: No Business Standard Journalist was involved in creation of this content